Catalyst Crew Technologies Corp. (OTC: CCTC), a digital health and artificial intelligence technology company, has announced the establishment of a wholly owned operating subsidiary in Venezuela. This move is part of the company's broader strategy to expand its healthcare technology initiatives in Latin America, focusing on telehealth infrastructure and AI-enabled healthcare analytics platforms.
The newly formed subsidiary will support local operations, infrastructure development, and the planned deployment of the company's digital health technologies, including telehealth services, remote patient monitoring, and AI-powered analytics. Management believes this presence is a critical step toward evaluating market opportunities, developing strategic partnerships, and implementing pilot programs in collaboration with healthcare providers within the country.
Catalyst Crew Technologies' AI healthcare platform includes modular systems such as CardioAI, PulmoAI, and NeuroAI, which are intended to be integrated into its broader healthcare services infrastructure. The company prioritizes market development in Latin America, where it believes technology-enabled solutions can expand access to medical services, improve diagnostic capabilities, and enhance healthcare delivery efficiency.
Dr. Kevin Rodan Levy, CEO of Catalyst Crew Technologies, stated: 'Establishing a local operating presence is an important step in executing our regional strategy. We believe that combining artificial intelligence-driven healthcare technologies with localized healthcare infrastructure can support more accessible and efficient delivery of medical services.'
The company intends to continue evaluating opportunities to expand its presence in Latin America while advancing its digital health and AI platform initiatives. For more information, visit https://catalystcrewai.com or review the company's filings with the U.S. Securities and Exchange Commission at www.sec.gov.
